Tesamorelin 10MG

Categories:

Tesamorelin 10MG is a peptide designed for research-use-only and laboratory contexts, intended for further scientific investigation. This compound has been explored for its potential effects on growth hormone signaling, though it is not for human or veterinary therapeutic use. For research use only.

$63.00

Satisfaction Guaranteed

Secure
Payment

Third-party
Tested

Research Use Disclaimer

Every serious peptide company prominently displays this. Example Research Use Only All products offered are intended strictly for laboratory research purposes. Products are not for human consumption and are not intended for diagnostic, therapeutic, or medical use. By purchasing from our website, customers confirm they are qualified researchers or laboratories and understand the intended research-use designation.

 

Tesamorelin 10MG

Tesamorelin is a research-use-only peptide with a primary focus on modulating growth hormone signaling pathways. This compound has been studied extensively in both preclinical and early clinical investigations under tightly controlled research conditions.

Research Context

Tesamorelin is a synthetic peptide analog derived from the growth hormone-releasing factor (GHRF) domain. Originally developed for its potential therapeutic applications, it has been primarily utilized in research settings to investigate its effects on muscle mass, fat distribution, and metabolic processes. Its mechanism of action primarily involves selective activation of the growth hormone-insulin-like growth factor-1 (GH-IGF-1) axis.

Research Overview

Tesamorelin has shown promise in preclinical studies for exploring how it may influence muscle atrophy and fat deposition under conditions such as HIV-associated lipodystrophy, cachexia, and metabolic syndrome. Early investigations have examined its role in counteracting muscle wasting and altering visceral adiposity, particularly in models requiring controlled administration protocols.

Key Research Focus Areas

  • Muscle Mass Regulation: Examination of its effects on skeletal muscle protein synthesis and degradation in research animal models.
  • Fat Distribution Modulation: Investigation of visceral fat reduction and altered lipid metabolism profiles.
  • Metabolic Pathway Analysis: Study of ghrelin receptor binding and downstream signaling in metabolic research.
  • Comparative Pharmacodynamics: Analysis of dose-response relationships in controlled research environments.

Safety and Compliance

Tesamorelin must be handled exclusively within approved research facilities by qualified personnel adhering to established Good Laboratory Practices (GLP). Administration protocols must be conducted in accordance with Institutional Review Board (IRB) and Institutional Animal Care and Use Committee (IACC) regulations when applied to animal studies. This product is intended solely for research purposes and not for therapeutic or diagnostic applications in humans or animals.

For research use only. Not for human or animal consumption.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

At Hollywood Peptides, we provide more than just industry-leading compounds; we provide the certainty and excellence required for groundbreaking results. We recognize that in the world of science, there is no room for error. That is why every formulation we offer is subjected to stringent validation and certification protocols.
 
Lab Report
Date Added :
04/28/2026

 

Tesamorelin 10MG

Tesamorelin is a research-use-only peptide with a primary focus on modulating growth hormone signaling pathways. This compound has been studied extensively in both preclinical and early clinical investigations under tightly controlled research conditions.

Research Context

Tesamorelin is a synthetic peptide analog derived from the growth hormone-releasing factor (GHRF) domain. Originally developed for its potential therapeutic applications, it has been primarily utilized in research settings to investigate its effects on muscle mass, fat distribution, and metabolic processes. Its mechanism of action primarily involves selective activation of the growth hormone-insulin-like growth factor-1 (GH-IGF-1) axis.

Research Overview

Tesamorelin has shown promise in preclinical studies for exploring how it may influence muscle atrophy and fat deposition under conditions such as HIV-associated lipodystrophy, cachexia, and metabolic syndrome. Early investigations have examined its role in counteracting muscle wasting and altering visceral adiposity, particularly in models requiring controlled administration protocols.

Key Research Focus Areas

  • Muscle Mass Regulation: Examination of its effects on skeletal muscle protein synthesis and degradation in research animal models.
  • Fat Distribution Modulation: Investigation of visceral fat reduction and altered lipid metabolism profiles.
  • Metabolic Pathway Analysis: Study of ghrelin receptor binding and downstream signaling in metabolic research.
  • Comparative Pharmacodynamics: Analysis of dose-response relationships in controlled research environments.

Safety and Compliance

Tesamorelin must be handled exclusively within approved research facilities by qualified personnel adhering to established Good Laboratory Practices (GLP). Administration protocols must be conducted in accordance with Institutional Review Board (IRB) and Institutional Animal Care and Use Committee (IACC) regulations when applied to animal studies. This product is intended solely for research purposes and not for therapeutic or diagnostic applications in humans or animals.

For research use only. Not for human or animal consumption.

Size

10MG

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin 10MG”

Your email address will not be published. Required fields are marked *

Related Peptides

Age Verification!

*By continuing, you confirm eligibility and legal compliance.